Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-010249
Filing Date
2019-06-06
Accepted
2019-06-06 19:27:48
Documents
1
Period of Report
2019-06-04

Document Format Files

Seq Description Document Type Size
1 4 s113104_form4.html 4  
1 4 s113104_form4.xml 4 3967
  Complete submission text file 0001213900-19-010249.txt   5447
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 51 WEST 52ND STREET, 7TH FLOOR NEW YORK NY 10019
Business Address
Boenisch Sandra (Reporting) CIK: 0001655366 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37606 | Film No.: 19883870